HCV treatment outcome depends on SNPs of IFNL3-Gene polymorphisms (rs12979860) and cirrhotic changes in liver parenchyma.

Autor: Abd Alla MDA; Department of Hepatology, Gastroenterology and Infectious Diseases, Faculty of Medicine, Al-Azhar University, Egypt., Dawood RM; Department of Microbial Biotechnology, National Research Centre, Cairo, Egypt., Rashed HAE; Department of Hepatology, Gastroenterology and Infectious Diseases, Faculty of Medicine, Al-Azhar University, Egypt., El-Dessouky YM; Department of Hepatology, Gastroenterology and Infectious Diseases, Faculty of Medicine, Al-Azhar University, Egypt., AbuFarrag GA; Department of Hepatology, Gastroenterology and Infectious Diseases, Faculty of Medicine, Al-Azhar University, Egypt., Ammar IAE; Department of Hepatology, Gastroenterology and Infectious Diseases, Faculty of Medicine, Al-Azhar University, Egypt., Mahmoud MMA; Department of Hepatology, Gastroenterology and Infectious Diseases, Faculty of Medicine, Al-Azhar University, Egypt., Salum GM; Department of Microbial Biotechnology, National Research Centre, Cairo, Egypt., Abu-Amer MZ; Department of Hepatology, Gastroenterology and Infectious Diseases, Faculty of Medicine, Al-Azhar University, Egypt., Sekeen MAEH; Department of Hepatology, Gastroenterology and Infectious Diseases, Faculty of Medicine, Al-Azhar University, Egypt., Heggazy MMI; Department of Hepatology, Gastroenterology and Infectious Diseases, Faculty of Medicine, Al-Azhar University, Egypt., Altanbouly AMA; Department of Hepatology, Gastroenterology and Infectious Diseases, Faculty of Medicine, Al-Azhar University, Egypt., Abd El-Meguid M; Department of Microbial Biotechnology, National Research Centre, Cairo, Egypt., El Awady MK; Department of Microbial Biotechnology, National Research Centre, Cairo, Egypt.

Publikováno v: Heliyon [Heliyon] 2023 Oct 19; Vol. 9 (11), pp. e21194. Date of Electronic Publication: 2023 Oct 19 (Print Publication: 2023).